Search Result "GLP-2"
Adapting the GLP-1-Signaling System to the Treatment of Type 2 Diabetes
Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 15-23
Author(s): Teresa Salvatore, Ornella Carbonara, Domenico Cozzolino, Roberto Torella, Ferdinando Carlo Sasso
Glucagon-Like Peptide 2 (GLP-2), An Intestinotrophic Mediator
Journal: Current Protein & Peptide Science
Volume: 5 Issue: 1 Year: 2004 Page: 51-65
Author(s): J. Thulesen
Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Journal: Current Diabetes Reviews
Volume: 6 Issue: 4 Year: 2010 Page: 191-200
Author(s): Danilo Verge, Ximena Lopez
GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 279-292
Author(s): Lalita Dahiya,Ramandeep Kaur,Rajiv Kumar,Manoj Kumar,Kezia Palta
The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6 Issue: 2 Year: 2012 Page: 129-135
Author(s): Manash P. Baruah,Sanjay Kalra
Developments of Glucagon Like Peptide-1 (GLP-1) and Long-acting Analogs in Clinical and Preclinical Studies for Treatment of Type 2 Diabetes
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 9 Year: 2013 Page: 835-841
Author(s): Yazhuo Li,Lida Tang,Min Gong
GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 6 Year: 2005 Page: 485-497
Author(s): Juris J. Meier, Michael A. Nauck
Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the Literature
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 4 Year: 2021 Page: 626-646
Author(s): Giuseppe Lisco,Anna De Tullio,Edoardo Guastamacchia,Vincenzo Triggiani
Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 17 Year: 2018 Page: 1879-1886
Author(s): Michael Doumas,Îonstantinos Imprialos,Konstantinos Stavropoulos,Andromachi Reklou,Alexandros Sachinidis,Vasilios G. Athyros
Expression and Purification of Optimized rolGLP-1, A Novel GLP-1 Analog, in Escherichia Coli BL21(DE3) and its Good Glucoregulatory Effect on Type 2 Diabetic Mice
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 11 Year: 2013 Page: 985-994
Author(s): Baicheng Ma,Peipei Tu,Xingyu Zhao,Yaofang Zhang,Yu Wang,Chao Ma,Yanli Ji,Xiaodan Li,Syed A. Abbas,Minggang Li